- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A GP journal insert presented as an “unrestricted educational grant” was ruled promotional, misleading and disguised. Data were selectively presented (incl. suppressed-zero…
A PCT complainant alleged a Champix “launch update” meeting invite primed stop-smoking advisers to drive public demand. PMCPA found attendees were appropriate…
A contract rep complained about high call-rate expectations. The Panel found an agency email advocated increased frequency likely to breach the Code,…
Shire was accused of breaching an undertaking by still using a paper previously linked to a misleading ad. PMCPA found that distributing…
PMCPA case AUTH/3000/12/17 (Director v Roche) concerning clinical trial disclosure for Gazyvaro. Outcome: no breach; matter outwith the scope of the Code.
PMCPA Director review into a clinical trial disclosure matter relating to Zinforo (Teflaro in the USA). The case was ruled outwith the…
AbbVie was found in breach for failing to accurately declare its involvement in an Embrace Stars poster and for using uncertified case-study…
A Pulse ad claimed Relvar Ellipta was “superior to other ICS/LABAs” based on the Salford Lung Study, but lacked key context and…
Novartis’ Nicotinell journal ad was ruled misleading for implying afternoon/evening craving “peaks” and for a “quit rates up to four times” claim…
Procter & Gamble admitted an Intrinsa (testosterone patch) ad appeared in a journal accessible to patients. The Panel ruled promotion of a…
Anonymous Teva rep alleged pressure to sign GP surgeries to an asthma review service linked to switching to Qvar. Appeal Board found…
Proveca sent a ‘cease and desist’ style letter to 16,154 pharmacies about dispensing glycopyrronium ‘specials’. PMCPA found the tone threatening, implied illegality…
A PCT complained an Abbott representative missed a rebooked appointment without explanation. The Panel found the second appointment was likely made for…
A mental health nurse challenged a Risperdal mailing as stigmatising and queried mailing list ethics and rep visit frequency. The Panel found…
Complaint about promotion of Juvederm Ultra. PMCPA concluded no breach because the matter was outwith the scope of the ABPI Code (2008).…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.